Molecule Details
| InChIKey | SSRDSYXGYPJKRR-ZDUSSCGKSA-N |
|---|---|
| Canonical SMILES | O=C(N[C@H]1CN2CCC1CC2)c1cc2cccc(Cl)c2s1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 7.35 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB11726 |
|---|---|
| Drug Name | Encenicline |
| CAS Number | 550999-75-2 |
| Groups | investigational |
| ATC Codes | nan |
| Description | Encenicline has been investigated for the treatment of Cognition, Schizophrenia, Alzheimer's Disease, Cardiac Repolarization, and Central Nervous System Diseases. |
Categories: Nicotinic Agonists Sulfur Compounds
Cross-references: BindingDB: 50393255 CHEMBL2151572 ChemSpider: 28637768 PDB: I33 PubChem:46196517 PubChem:347828087 Wikipedia: Encenicline ZINC: ZINC000095579362
Target Activities (2)
DrugBank Target Actions (1)
| Target | Gene | Target Name | Action | Type |
|---|---|---|---|---|
| P36544 | CHRNA7 | Neuronal acetylcholine receptor subunit alpha-7 | partial agonist | targets |